vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and ESSENTIAL PROPERTIES REALTY TRUST, INC. (EPRT). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $158.8M, roughly 1.8× ESSENTIAL PROPERTIES REALTY TRUST, INC.). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 37.8%, a 58.6% gap on every dollar of revenue. On growth, ESSENTIAL PROPERTIES REALTY TRUST, INC. posted the faster year-over-year revenue change (22.8% vs 9.4%). Over the past eight quarters, ESSENTIAL PROPERTIES REALTY TRUST, INC.'s revenue compounded faster (20.6% CAGR vs 17.5%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Essential Properties Realty Trust is a publicly traded real estate investment trust (REIT) that acquires, owns and manages a diversified portfolio of single-tenant net-leased commercial properties across the United States. Its assets primarily cover essential service-oriented sectors including casual dining, automotive services, medical clinics, early childhood education centers and light industrial facilities, with tenants mostly holding robust long-term operating track records.
ACAD vs EPRT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $284.0M | $158.8M |
| Net Profit | $273.6M | $60.0M |
| Gross Margin | 90.8% | — |
| Operating Margin | 6.1% | 56.5% |
| Net Margin | 96.3% | 37.8% |
| Revenue YoY | 9.4% | 22.8% |
| Net Profit YoY | 90.3% | 6.5% |
| EPS (diluted) | $1.61 | $0.28 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $158.8M | ||
| Q4 25 | $284.0M | $149.9M | ||
| Q3 25 | $278.6M | $144.9M | ||
| Q2 25 | $264.6M | $137.1M | ||
| Q1 25 | $244.3M | $129.4M | ||
| Q4 24 | $259.6M | $119.7M | ||
| Q3 24 | $250.4M | $117.1M | ||
| Q2 24 | $242.0M | $109.3M |
| Q1 26 | — | $60.0M | ||
| Q4 25 | $273.6M | $68.1M | ||
| Q3 25 | $71.8M | $65.6M | ||
| Q2 25 | $26.7M | $63.2M | ||
| Q1 25 | $19.0M | $56.1M | ||
| Q4 24 | $143.7M | $55.4M | ||
| Q3 24 | $32.8M | $49.1M | ||
| Q2 24 | $33.4M | $51.5M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | — | 56.5% | ||
| Q4 25 | 6.1% | 65.9% | ||
| Q3 25 | 12.8% | 64.7% | ||
| Q2 25 | 12.2% | 64.1% | ||
| Q1 25 | 7.9% | 61.6% | ||
| Q4 24 | 59.1% | 66.1% | ||
| Q3 24 | 12.6% | 59.7% | ||
| Q2 24 | 12.6% | 61.1% |
| Q1 26 | — | 37.8% | ||
| Q4 25 | 96.3% | 45.4% | ||
| Q3 25 | 25.8% | 45.3% | ||
| Q2 25 | 10.1% | 46.1% | ||
| Q1 25 | 7.8% | 43.4% | ||
| Q4 24 | 55.4% | 46.3% | ||
| Q3 24 | 13.1% | 42.0% | ||
| Q2 24 | 13.8% | 47.1% |
| Q1 26 | — | $0.28 | ||
| Q4 25 | $1.61 | $0.34 | ||
| Q3 25 | $0.42 | $0.33 | ||
| Q2 25 | $0.16 | $0.32 | ||
| Q1 25 | $0.11 | $0.29 | ||
| Q4 24 | $0.86 | $0.31 | ||
| Q3 24 | $0.20 | $0.27 | ||
| Q2 24 | $0.20 | $0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $177.7M | $15.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $4.4B |
| Total Assets | $1.6B | $7.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $15.2M | ||
| Q4 25 | $177.7M | $60.2M | ||
| Q3 25 | $258.0M | $23.8M | ||
| Q2 25 | $253.6M | $20.8M | ||
| Q1 25 | $217.7M | $47.0M | ||
| Q4 24 | $319.6M | $40.7M | ||
| Q3 24 | $155.1M | $32.7M | ||
| Q2 24 | $177.1M | $23.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.5B | ||
| Q3 25 | — | $2.6B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $1.9B |
| Q1 26 | — | $4.4B | ||
| Q4 25 | $1.2B | $4.2B | ||
| Q3 25 | $917.3M | $3.8B | ||
| Q2 25 | $822.4M | $3.8B | ||
| Q1 25 | $765.2M | $3.8B | ||
| Q4 24 | $732.8M | $3.6B | ||
| Q3 24 | $577.2M | $3.2B | ||
| Q2 24 | $516.7M | $3.2B |
| Q1 26 | — | $7.2B | ||
| Q4 25 | $1.6B | $6.9B | ||
| Q3 25 | $1.3B | $6.6B | ||
| Q2 25 | $1.2B | $6.3B | ||
| Q1 25 | $1.1B | $6.1B | ||
| Q4 24 | $1.2B | $5.8B | ||
| Q3 24 | $976.9M | $5.5B | ||
| Q2 24 | $914.1M | $5.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.60× | ||
| Q3 25 | — | 0.69× | ||
| Q2 25 | — | 0.61× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 0.69× | ||
| Q2 24 | — | 0.59× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.7M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | -0.18× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $381.1M | ||
| Q3 25 | $74.3M | $99.0M | ||
| Q2 25 | $64.0M | $99.8M | ||
| Q1 25 | $20.3M | $77.2M | ||
| Q4 24 | $40.4M | $308.5M | ||
| Q3 24 | $63.2M | $73.5M | ||
| Q2 24 | $25.0M | $81.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $73.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $63.2M | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 26.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 25.2% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | 5.60× | ||
| Q3 25 | 1.03× | 1.51× | ||
| Q2 25 | 2.40× | 1.58× | ||
| Q1 25 | 1.07× | 1.38× | ||
| Q4 24 | 0.28× | 5.57× | ||
| Q3 24 | 1.93× | 1.50× | ||
| Q2 24 | 0.75× | 1.57× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
| Nuplazid | $174.4M | 61% |
| Daybue | $109.6M | 39% |
EPRT
| Rental revenue 1,2 | $149.4M | 94% |
| Other | $8.6M | 5% |
| Other revenue | $779.0K | 0% |
